Circulating microvesicles across a population with various degree of cardiovascular burden are associated with systolic blood pressure
Circulating microvesicles (MVs) have been studied in heterogeneous, divergent, and rather small patient populations with cardiovascular risk . Therefore, we measured endothelial (EMVs), platelet (PMVs) and erythrocyte (RMVs) MVs in patients with divergent cardiovascular risk. We then compared them t...
Gespeichert in:
| Veröffentlicht in: | Journal of human hypertension 2023-12, Vol.37 (12), p.1105-1111 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1111 |
|---|---|
| container_issue | 12 |
| container_start_page | 1105 |
| container_title | Journal of human hypertension |
| container_volume | 37 |
| creator | Gavriilaki, Eleni Lazaridis, Antonios Anyfanti, Panagiota Yiannaki, Efthalia Dolgyras, Panagiotis Nikolaidou, Barbara Vasileiadis, Ioannis Alexandrou, Maria Eleni Margouta, Anastasia Markala, Dimitra Zarifis, Ioannis Sarafidis, Panteleimon Doumas, Michail Gkaliagkousi, Eugenia |
| description | Circulating microvesicles (MVs) have been studied in heterogeneous, divergent, and rather small patient populations with cardiovascular risk . Therefore, we measured endothelial (EMVs), platelet (PMVs) and erythrocyte (RMVs) MVs in patients with divergent cardiovascular risk. We then compared them to coronary artery disease (CAD) and healthy subjects and identified independent MVs’ predictors. We enrolled consecutive patients from our Cardiology, Hypertension, Diabetic, Rheumatic, and Nephrology Outpatient Units with MVs measurements. Central blood pressure (BP) was measured by either applanation tonometry or Mobil-O-graph device, while MVs by a standardized flow cytometry protocol. We studied 369 participants with increased cardiovascular risk: 63 with high cardiovascular risk (47 diabetes mellitus type II/DM and 16 end-stage renal disease/ESRD), 92 with chronic inflammatory disorders and 73 with untreated essential hypertension/UEH. We further included 53 subjects with CAD and 87 otherwise healthy individuals. All MVs were lower in patients with increased cardiovascular risk compared to CAD, showing predictive value with high sensitivity and specificity. Furthermore, PMVs and EMVs were increased in patients with cardiovascular risk compared to healthy individuals. DM and ESRD patients had increased EMVs versus UEH and chronic inflammatory disorders. In the whole study population, RMVs were associated only with history of essential hypertension. In multivariate analysis, systolic BP predicted PMVs. Aage, systolic BP, and DM predicted EMVs. In a large population of patients with divergent cardiovascular risk, MVs are independently associated with systolic blood pressure. |
| doi_str_mv | 10.1038/s41371-023-00854-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2905524558</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2904474418</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-a0252908d3590b4d7db55646c9eb5092f80e2a97373a659f3a03df8f33913d6d3</originalsourceid><addsrcrecordid>eNp9kctu1TAQhi1ERUvhBVggS2zYhPoaJ0t0VFqkSmxgbTn25OAqJw6e5KC-AM-Nc1IuYsFqfPn-f-z5CXnF2TvOZHOFikvDKyZkxVijVVU_IRdcmbrSWpinf63PyXPEe8bWg-YZOZem5kIJfkF-7GL2y-DmOO7pIfqcjoDRD4DUlQ2WQqc0nYg00u9x_kqPLse0IA2wzwA09dS7HGI6OlytMu2WHGCkLgN1iMlHN0PYtPiAcxqip92QUqBTBsQlwwty1rsB4eVjvSRfPlx_3t1Wd59uPu7e31VeGj1XjgktWtYEqVvWqWBCp3Wtat9Cp1kr-oaBcK2RRrpat710TIa-6aVsuQx1kJfk7eY75fRtAZztIaKHYXAjlC_ZYl7mpbRuCvrmH_Q-LXksr1sppYxSfKXERp2GlaG3U44Hlx8sZ3ZNyW4p2ZKSPaVk6yJ6_Wi9dAcIvyW_YimA3AAsV-Me8p_e_7H9Cf-On1g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2904474418</pqid></control><display><type>article</type><title>Circulating microvesicles across a population with various degree of cardiovascular burden are associated with systolic blood pressure</title><source>SpringerLink Journals</source><creator>Gavriilaki, Eleni ; Lazaridis, Antonios ; Anyfanti, Panagiota ; Yiannaki, Efthalia ; Dolgyras, Panagiotis ; Nikolaidou, Barbara ; Vasileiadis, Ioannis ; Alexandrou, Maria Eleni ; Margouta, Anastasia ; Markala, Dimitra ; Zarifis, Ioannis ; Sarafidis, Panteleimon ; Doumas, Michail ; Gkaliagkousi, Eugenia</creator><creatorcontrib>Gavriilaki, Eleni ; Lazaridis, Antonios ; Anyfanti, Panagiota ; Yiannaki, Efthalia ; Dolgyras, Panagiotis ; Nikolaidou, Barbara ; Vasileiadis, Ioannis ; Alexandrou, Maria Eleni ; Margouta, Anastasia ; Markala, Dimitra ; Zarifis, Ioannis ; Sarafidis, Panteleimon ; Doumas, Michail ; Gkaliagkousi, Eugenia</creatorcontrib><description>Circulating microvesicles (MVs) have been studied in heterogeneous, divergent, and rather small patient populations with cardiovascular risk . Therefore, we measured endothelial (EMVs), platelet (PMVs) and erythrocyte (RMVs) MVs in patients with divergent cardiovascular risk. We then compared them to coronary artery disease (CAD) and healthy subjects and identified independent MVs’ predictors. We enrolled consecutive patients from our Cardiology, Hypertension, Diabetic, Rheumatic, and Nephrology Outpatient Units with MVs measurements. Central blood pressure (BP) was measured by either applanation tonometry or Mobil-O-graph device, while MVs by a standardized flow cytometry protocol. We studied 369 participants with increased cardiovascular risk: 63 with high cardiovascular risk (47 diabetes mellitus type II/DM and 16 end-stage renal disease/ESRD), 92 with chronic inflammatory disorders and 73 with untreated essential hypertension/UEH. We further included 53 subjects with CAD and 87 otherwise healthy individuals. All MVs were lower in patients with increased cardiovascular risk compared to CAD, showing predictive value with high sensitivity and specificity. Furthermore, PMVs and EMVs were increased in patients with cardiovascular risk compared to healthy individuals. DM and ESRD patients had increased EMVs versus UEH and chronic inflammatory disorders. In the whole study population, RMVs were associated only with history of essential hypertension. In multivariate analysis, systolic BP predicted PMVs. Aage, systolic BP, and DM predicted EMVs. In a large population of patients with divergent cardiovascular risk, MVs are independently associated with systolic blood pressure.</description><identifier>ISSN: 1476-5527</identifier><identifier>ISSN: 0950-9240</identifier><identifier>EISSN: 1476-5527</identifier><identifier>DOI: 10.1038/s41371-023-00854-6</identifier><identifier>PMID: 37612421</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/308 ; 692/499 ; 82 ; 82/1 ; Blood pressure ; Cardiovascular disease ; Cardiovascular diseases ; Coronary artery disease ; Diabetes mellitus ; End-stage renal disease ; Epidemiology ; Flow cytometry ; Health Administration ; Heart diseases ; Hypertension ; Inflammatory diseases ; Kidney diseases ; Medicine ; Medicine & Public Health ; Multivariate analysis ; Population studies ; Public Health ; Review Article</subject><ispartof>Journal of human hypertension, 2023-12, Vol.37 (12), p.1105-1111</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer Nature Limited.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-a0252908d3590b4d7db55646c9eb5092f80e2a97373a659f3a03df8f33913d6d3</citedby><cites>FETCH-LOGICAL-c375t-a0252908d3590b4d7db55646c9eb5092f80e2a97373a659f3a03df8f33913d6d3</cites><orcidid>0000-0002-8883-8208 ; 0000-0002-5658-4629 ; 0000-0002-0261-065X ; 0000-0002-7205-4644 ; 0000-0002-6324-2475 ; 0000-0003-3526-261X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41371-023-00854-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41371-023-00854-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37612421$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gavriilaki, Eleni</creatorcontrib><creatorcontrib>Lazaridis, Antonios</creatorcontrib><creatorcontrib>Anyfanti, Panagiota</creatorcontrib><creatorcontrib>Yiannaki, Efthalia</creatorcontrib><creatorcontrib>Dolgyras, Panagiotis</creatorcontrib><creatorcontrib>Nikolaidou, Barbara</creatorcontrib><creatorcontrib>Vasileiadis, Ioannis</creatorcontrib><creatorcontrib>Alexandrou, Maria Eleni</creatorcontrib><creatorcontrib>Margouta, Anastasia</creatorcontrib><creatorcontrib>Markala, Dimitra</creatorcontrib><creatorcontrib>Zarifis, Ioannis</creatorcontrib><creatorcontrib>Sarafidis, Panteleimon</creatorcontrib><creatorcontrib>Doumas, Michail</creatorcontrib><creatorcontrib>Gkaliagkousi, Eugenia</creatorcontrib><title>Circulating microvesicles across a population with various degree of cardiovascular burden are associated with systolic blood pressure</title><title>Journal of human hypertension</title><addtitle>J Hum Hypertens</addtitle><addtitle>J Hum Hypertens</addtitle><description>Circulating microvesicles (MVs) have been studied in heterogeneous, divergent, and rather small patient populations with cardiovascular risk . Therefore, we measured endothelial (EMVs), platelet (PMVs) and erythrocyte (RMVs) MVs in patients with divergent cardiovascular risk. We then compared them to coronary artery disease (CAD) and healthy subjects and identified independent MVs’ predictors. We enrolled consecutive patients from our Cardiology, Hypertension, Diabetic, Rheumatic, and Nephrology Outpatient Units with MVs measurements. Central blood pressure (BP) was measured by either applanation tonometry or Mobil-O-graph device, while MVs by a standardized flow cytometry protocol. We studied 369 participants with increased cardiovascular risk: 63 with high cardiovascular risk (47 diabetes mellitus type II/DM and 16 end-stage renal disease/ESRD), 92 with chronic inflammatory disorders and 73 with untreated essential hypertension/UEH. We further included 53 subjects with CAD and 87 otherwise healthy individuals. All MVs were lower in patients with increased cardiovascular risk compared to CAD, showing predictive value with high sensitivity and specificity. Furthermore, PMVs and EMVs were increased in patients with cardiovascular risk compared to healthy individuals. DM and ESRD patients had increased EMVs versus UEH and chronic inflammatory disorders. In the whole study population, RMVs were associated only with history of essential hypertension. In multivariate analysis, systolic BP predicted PMVs. Aage, systolic BP, and DM predicted EMVs. In a large population of patients with divergent cardiovascular risk, MVs are independently associated with systolic blood pressure.</description><subject>692/308</subject><subject>692/499</subject><subject>82</subject><subject>82/1</subject><subject>Blood pressure</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Coronary artery disease</subject><subject>Diabetes mellitus</subject><subject>End-stage renal disease</subject><subject>Epidemiology</subject><subject>Flow cytometry</subject><subject>Health Administration</subject><subject>Heart diseases</subject><subject>Hypertension</subject><subject>Inflammatory diseases</subject><subject>Kidney diseases</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Multivariate analysis</subject><subject>Population studies</subject><subject>Public Health</subject><subject>Review Article</subject><issn>1476-5527</issn><issn>0950-9240</issn><issn>1476-5527</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp9kctu1TAQhi1ERUvhBVggS2zYhPoaJ0t0VFqkSmxgbTn25OAqJw6e5KC-AM-Nc1IuYsFqfPn-f-z5CXnF2TvOZHOFikvDKyZkxVijVVU_IRdcmbrSWpinf63PyXPEe8bWg-YZOZem5kIJfkF-7GL2y-DmOO7pIfqcjoDRD4DUlQ2WQqc0nYg00u9x_kqPLse0IA2wzwA09dS7HGI6OlytMu2WHGCkLgN1iMlHN0PYtPiAcxqip92QUqBTBsQlwwty1rsB4eVjvSRfPlx_3t1Wd59uPu7e31VeGj1XjgktWtYEqVvWqWBCp3Wtat9Cp1kr-oaBcK2RRrpat710TIa-6aVsuQx1kJfk7eY75fRtAZztIaKHYXAjlC_ZYl7mpbRuCvrmH_Q-LXksr1sppYxSfKXERp2GlaG3U44Hlx8sZ3ZNyW4p2ZKSPaVk6yJ6_Wi9dAcIvyW_YimA3AAsV-Me8p_e_7H9Cf-On1g</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Gavriilaki, Eleni</creator><creator>Lazaridis, Antonios</creator><creator>Anyfanti, Panagiota</creator><creator>Yiannaki, Efthalia</creator><creator>Dolgyras, Panagiotis</creator><creator>Nikolaidou, Barbara</creator><creator>Vasileiadis, Ioannis</creator><creator>Alexandrou, Maria Eleni</creator><creator>Margouta, Anastasia</creator><creator>Markala, Dimitra</creator><creator>Zarifis, Ioannis</creator><creator>Sarafidis, Panteleimon</creator><creator>Doumas, Michail</creator><creator>Gkaliagkousi, Eugenia</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8883-8208</orcidid><orcidid>https://orcid.org/0000-0002-5658-4629</orcidid><orcidid>https://orcid.org/0000-0002-0261-065X</orcidid><orcidid>https://orcid.org/0000-0002-7205-4644</orcidid><orcidid>https://orcid.org/0000-0002-6324-2475</orcidid><orcidid>https://orcid.org/0000-0003-3526-261X</orcidid></search><sort><creationdate>20231201</creationdate><title>Circulating microvesicles across a population with various degree of cardiovascular burden are associated with systolic blood pressure</title><author>Gavriilaki, Eleni ; Lazaridis, Antonios ; Anyfanti, Panagiota ; Yiannaki, Efthalia ; Dolgyras, Panagiotis ; Nikolaidou, Barbara ; Vasileiadis, Ioannis ; Alexandrou, Maria Eleni ; Margouta, Anastasia ; Markala, Dimitra ; Zarifis, Ioannis ; Sarafidis, Panteleimon ; Doumas, Michail ; Gkaliagkousi, Eugenia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-a0252908d3590b4d7db55646c9eb5092f80e2a97373a659f3a03df8f33913d6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>692/308</topic><topic>692/499</topic><topic>82</topic><topic>82/1</topic><topic>Blood pressure</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Coronary artery disease</topic><topic>Diabetes mellitus</topic><topic>End-stage renal disease</topic><topic>Epidemiology</topic><topic>Flow cytometry</topic><topic>Health Administration</topic><topic>Heart diseases</topic><topic>Hypertension</topic><topic>Inflammatory diseases</topic><topic>Kidney diseases</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Multivariate analysis</topic><topic>Population studies</topic><topic>Public Health</topic><topic>Review Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gavriilaki, Eleni</creatorcontrib><creatorcontrib>Lazaridis, Antonios</creatorcontrib><creatorcontrib>Anyfanti, Panagiota</creatorcontrib><creatorcontrib>Yiannaki, Efthalia</creatorcontrib><creatorcontrib>Dolgyras, Panagiotis</creatorcontrib><creatorcontrib>Nikolaidou, Barbara</creatorcontrib><creatorcontrib>Vasileiadis, Ioannis</creatorcontrib><creatorcontrib>Alexandrou, Maria Eleni</creatorcontrib><creatorcontrib>Margouta, Anastasia</creatorcontrib><creatorcontrib>Markala, Dimitra</creatorcontrib><creatorcontrib>Zarifis, Ioannis</creatorcontrib><creatorcontrib>Sarafidis, Panteleimon</creatorcontrib><creatorcontrib>Doumas, Michail</creatorcontrib><creatorcontrib>Gkaliagkousi, Eugenia</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of human hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gavriilaki, Eleni</au><au>Lazaridis, Antonios</au><au>Anyfanti, Panagiota</au><au>Yiannaki, Efthalia</au><au>Dolgyras, Panagiotis</au><au>Nikolaidou, Barbara</au><au>Vasileiadis, Ioannis</au><au>Alexandrou, Maria Eleni</au><au>Margouta, Anastasia</au><au>Markala, Dimitra</au><au>Zarifis, Ioannis</au><au>Sarafidis, Panteleimon</au><au>Doumas, Michail</au><au>Gkaliagkousi, Eugenia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Circulating microvesicles across a population with various degree of cardiovascular burden are associated with systolic blood pressure</atitle><jtitle>Journal of human hypertension</jtitle><stitle>J Hum Hypertens</stitle><addtitle>J Hum Hypertens</addtitle><date>2023-12-01</date><risdate>2023</risdate><volume>37</volume><issue>12</issue><spage>1105</spage><epage>1111</epage><pages>1105-1111</pages><issn>1476-5527</issn><issn>0950-9240</issn><eissn>1476-5527</eissn><abstract>Circulating microvesicles (MVs) have been studied in heterogeneous, divergent, and rather small patient populations with cardiovascular risk . Therefore, we measured endothelial (EMVs), platelet (PMVs) and erythrocyte (RMVs) MVs in patients with divergent cardiovascular risk. We then compared them to coronary artery disease (CAD) and healthy subjects and identified independent MVs’ predictors. We enrolled consecutive patients from our Cardiology, Hypertension, Diabetic, Rheumatic, and Nephrology Outpatient Units with MVs measurements. Central blood pressure (BP) was measured by either applanation tonometry or Mobil-O-graph device, while MVs by a standardized flow cytometry protocol. We studied 369 participants with increased cardiovascular risk: 63 with high cardiovascular risk (47 diabetes mellitus type II/DM and 16 end-stage renal disease/ESRD), 92 with chronic inflammatory disorders and 73 with untreated essential hypertension/UEH. We further included 53 subjects with CAD and 87 otherwise healthy individuals. All MVs were lower in patients with increased cardiovascular risk compared to CAD, showing predictive value with high sensitivity and specificity. Furthermore, PMVs and EMVs were increased in patients with cardiovascular risk compared to healthy individuals. DM and ESRD patients had increased EMVs versus UEH and chronic inflammatory disorders. In the whole study population, RMVs were associated only with history of essential hypertension. In multivariate analysis, systolic BP predicted PMVs. Aage, systolic BP, and DM predicted EMVs. In a large population of patients with divergent cardiovascular risk, MVs are independently associated with systolic blood pressure.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>37612421</pmid><doi>10.1038/s41371-023-00854-6</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-8883-8208</orcidid><orcidid>https://orcid.org/0000-0002-5658-4629</orcidid><orcidid>https://orcid.org/0000-0002-0261-065X</orcidid><orcidid>https://orcid.org/0000-0002-7205-4644</orcidid><orcidid>https://orcid.org/0000-0002-6324-2475</orcidid><orcidid>https://orcid.org/0000-0003-3526-261X</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1476-5527 |
| ispartof | Journal of human hypertension, 2023-12, Vol.37 (12), p.1105-1111 |
| issn | 1476-5527 0950-9240 1476-5527 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2905524558 |
| source | SpringerLink Journals |
| subjects | 692/308 692/499 82 82/1 Blood pressure Cardiovascular disease Cardiovascular diseases Coronary artery disease Diabetes mellitus End-stage renal disease Epidemiology Flow cytometry Health Administration Heart diseases Hypertension Inflammatory diseases Kidney diseases Medicine Medicine & Public Health Multivariate analysis Population studies Public Health Review Article |
| title | Circulating microvesicles across a population with various degree of cardiovascular burden are associated with systolic blood pressure |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T16%3A53%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Circulating%20microvesicles%20across%20a%20population%20with%20various%20degree%20of%20cardiovascular%20burden%20are%20associated%20with%20systolic%20blood%20pressure&rft.jtitle=Journal%20of%20human%20hypertension&rft.au=Gavriilaki,%20Eleni&rft.date=2023-12-01&rft.volume=37&rft.issue=12&rft.spage=1105&rft.epage=1111&rft.pages=1105-1111&rft.issn=1476-5527&rft.eissn=1476-5527&rft_id=info:doi/10.1038/s41371-023-00854-6&rft_dat=%3Cproquest_cross%3E2904474418%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2904474418&rft_id=info:pmid/37612421&rfr_iscdi=true |